TEHRAN (Iran News) – Iranian Deputy Minister of Health, Treatment and Medical Education Mohammad Reza Shanehsaz emphasized that the country is able to produce nearly all its needed medicine despite the US sanctions. Iran’s self-sufficiency in medications is an achievement needed to be accomplished. Iran is currently able to produce %99 of medicine needed by […]
TEHRAN (Iran News) – Iranian Deputy Minister of Health, Treatment and Medical Education Mohammad Reza Shanehsaz emphasized that the country is able to produce nearly all its needed medicine despite the US sanctions. Iran’s self-sufficiency in medications is an achievement needed to be accomplished.
Iran is currently able to produce %99 of medicine needed by patients with the remaining one percent either not being cost-effective to be produced domestically or it is a totally new product in the world, Shanehsaz said, addressing the 16th Conference on Iran’s Pharmaceutical Sciences in Kermanshah on Wednesday.
He added that some 180 medicines will be produced in Iran within two years, which will save 250 million dollars in the currency for the country.
“Currently, Iran has a special status in terms of scientific products in the field of pharmaceuticals, which is indebted to the efforts of the local experts and elites,” Shanehsaz said.
While the enemies are seeking to create problems for the country, it has attained self-sufficiency in producing medicine, he said, noting that there is no shortage of medicine despite sanctions and pressure piled on the country.
Iran has taken long strides in producing different types of drugs and medical equipment and exported them to many foreign states.
A recent report by the scientific and technological department of Iran’s presidential office said that the country is able to produce 97% of its needs to drugs indigenously.
in July, Iranian Vice-President for Science and Technology Sorena Sattari unveiled 8 new drugs during his visit to knowledge-based companies in Alborz province near Tehran.
The newly-developed drugs included Micro-Peltamparazole, Tamsulosin hydrochloride, Naltrexone base, Citalyptin phosphate, Peo glitazone, and other medicine.
As a result of Iran’s self-sufficiency in medications, the drugs have applications in the treatment of digestive diseases and intestinal insufficiency, and will also be exported to the regional states.
- source : FNA, Iran News
